Search for: "BM"
Results 81 - 100
of 383
Sorted by Relevance
|
Sort by Date
4 Nov 2010, 9:59 pm
By James DeGiulio -- Sanofi and BMS Awarded $442M in Plavix Patent Suit Apotex has been ordered to pay $442.2 million in damages to sanofi-aventis and Bristol-Myers Squibb Co. for infringing their patent covering the blood thinner Plavix. [read post]
12 Jan 2019, 10:12 am
On January 11, 2019, Congressman Peter Welch and Francis Rooney, members of Congress, wrote a letter to the Federal Trade Commission (“FTC”), urging the Commission to investigate Bristol-Myers Squibb’s (“BMS”) acquisition of Celgene. [read post]
12 Apr 2012, 4:54 am
BM-patented floor could detect a heart attack, call the cops http://zite.to/HxKHcb 38% of Children on Facebook Are Younger Than 12 http://zite.to/HCe09v Microsoft Gets Legal Reprieve in Patent Dispute With Motorola http://zite.to/Htzepf Canada | CFIA developing online self-assessment tool for label compliance, remove food container size restrictions http://bit.ly/Htyr7D Latest amendments to Canadian trade-marks Wares & Services Manual focus on cloud computing, “smart”… [read post]
3 Nov 2024, 9:01 pm
In BM Brazil & Ors v Sibanye BM Brazil & Anor [2024] EWHC 2566 (Comm), the English Commercial Court decided a buyer was not entitled to rely on a material adverse effect (“MAE”) condition to terminate an M&A transaction, extensively citing U.S. case law and commentary. [read post]
6 Apr 2011, 2:17 am
Court of Appeal (Civil Division) Makisi v Birmingham City Council [2011] EWCA Civ 355 (31 March 2011) BM v Secretary of State for the Home Department [2011] EWCA Civ 366 (05 April 2011) High Court (Queen’s Bench Division) Le Breton v Petrpodel Resources Ltd [2011] EWHC 769 (QB) (01 April 2011) High Court (Chancery Division) JSC BTA Bank v Solodchenko & Ors [2011] EWHC 843 (Ch) (05 April 2011) High Court (Administrative Court) Panesar (t/a Anami Law), R (on the application of) v… [read post]
21 Nov 2010, 9:02 pm
Bristol-Myers Squibb Co. 2:10-cv-00497; filed November 18, 2010 in the Eastern District of Texas False marking based on BMS' marking of its Cefzil products, its Buspar products, and its Pravachol products U.S. [read post]
19 Nov 2011, 12:53 pm
From NAFSA: The Department of State (DoS) has recently identified difficulties with its Consolidated Consular Database (CCD) communicating with the Student and Exchange Visitor Program’s (SEVP) Student and Exchange Visitor Information System (SEVIS). http://www.nafsa.org/uploadedFiles/BM%201111-02%20DoS%20Not%20Issuing%20F%20M%20or%20J%20Visas.pdf DoS discovered this issue on November 14, 2011. [read post]
4 Jan 2019, 9:16 pm
The COMP asked BMS to demonstrate the significant benefit of Empliciti over Kyprolis. [read post]
25 Jan 2017, 7:38 am
Law360 reports that Bristol-Myers Squibb and Pfizer are facing a $10 million suit for failing to disclose the risks of their Eliquis blood thinner. [read post]
16 Sep 2024, 9:47 am
The case, which was lodged by the pharmaceutical giant Bristol Myers Squibb (“BMS”) and consolidated with several other pharmaceutical challenges, alleges that the Inflation Reduction Act (IRA) compels drug manufacturers to provide Medicare with “access” to their leading medicines at steep discounts, effectuating to an unconstitutional taking in violation of the Fifth Amendment. [read post]
14 Nov 2024, 6:00 am
Superior Court of California, San Francisco County (“BMS”), holding the Fourteenth Amendment prevents a state court from adjudicating non-resident plaintiffs’ state-law claims. [read post]
16 Sep 2024, 9:47 am
The case, which was lodged by the pharmaceutical giant Bristol Myers Squibb (“BMS”) and consolidated with several other pharmaceutical challenges, alleges that the Inflation Reduction Act (IRA) compels drug manufacturers to provide Medicare with “access” to their leading medicines at steep discounts, effectuating to an unconstitutional taking in violation of the Fifth Amendment. [read post]
26 Apr 2017, 7:49 am
Yesterday the Supreme Court held oral arguments in a personal jurisdiction case involving purchasers of the drug Plavix who bought the drug in Ohio but wanted to join a suit in California where the company does almost 1 billion dollars... [read post]
7 Apr 2010, 9:44 am
The BMS case highlights the need for clear and unambiguous drafting in licence agreements (and in any amendments to licence agreements). [read post]
Will New Black Box Warning About Heart Attacks Lead GlaxoSmithKline To Withdraw Avandia From Market?
9 Nov 2007, 9:03 am
In turn, GlaxoSmithKline could follow the lead of Bristol-Myers Squibb (BMS) when that drug company experienced increasing scrutiny about the safety of its antibiotic Tequin in 2006. [read post]
27 Oct 2010, 6:45 pm
" In the agency's warning letter to BMS, the FDA told the company that "it could hold up approval of new products if the deficiencies are not corrected quickly. [read post]
15 Dec 2008, 9:51 pm
RELATED READING: Sanofi/BMS press release Apotex press release Bloomberg article Previous OBB posts: 8/8/06 (Apotex launches at-risk); 12/10/06 (Fed. [read post]
15 Jan 2009, 3:35 am
By Vandana Mamidanna Following on from this week's IP Think Tank podcast which analysed the BMS v Hetero case. [read post]
6 Sep 2024, 5:11 am
Baltimore Medical System celebrated the launch of two new programs to help improve health outcomes in pregnancy and early childhood. [read post]
26 Oct 2007, 10:39 am
Interestingly, the company created this popular drug while attempting to design around a megestrol patent owned by BMS. [read post]
